ArticleMultiple sclerosis and related disorders2022

Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.

Riccardo Giossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.